Trump Management Announces Landmark Deal to slash IVF Drug Costs, Eyes Ozempic price cuts
Table of Contents
A new initiative unveiled Friday promises meaningful savings for families undergoing in-vitro fertilization (IVF), while also signaling a broader push to lower prescription drug prices across the board. The administration announced a deal with Merck to reduce the cost of certain fertility drugs by as much as 84 percent.
The deal, announced during an event at the White House, hinges on a reciprocal arrangement: in exchange for the price cuts on IVF medications, Merck will be exempt from U.S. tariffs on other drugs it manufactures and exports to the united States.”other countries are agreeing to it,because if we don’t,we’ll put tariffs on them. And then they agree,” a senior official stated.
The High Cost of Starting a Family
The financial burden of IVF is substantial. according to industry data, a typical IVF cycle can range from $12,000 to $25,000 without insurance coverage. Compounding the issue, approximately seven in ten Americans currently lack insurance coverage for IVF treatments. While the current agreement won’t cover the entire cost of a cycle, the White House estimates families could save around $2,200 per cycle through the discounted medications. The savings will apply to three commonly used medications in the IVF process.
Beyond IVF: Targeting Ozempic and Other High-Priced Drugs
The administration’s ambitions extend beyond fertility treatments.During the same event, the president indicated that other expensive brand-name medications are also in the crosshairs, specifically mentioning Ozempic, the popular weight-loss drug manufactured by Novo Nordisk of Denmark. “Referring to Ozempic-the fat loss drug-it’ll be much lower,” the president said.
However, negotiations regarding Ozempic are still in their early stages. Dr. mehmet Oz, Administrator for the Centers of Medicare and Medicaid services, intervened to clarify that a deal has not yet been finalized, stating, “We have not negotiated that one yet.” The administration reportedly plans to leverage potential tariffs on Novo Nordisk to drive down the price of Ozempic, aiming for a reduction from its current cost of approximately $500 per month to $150.
International Price Disparities and Lack of Clarity
The president has been vocal in criticizing pharmaceutical companies for charging considerably higher prices to American consumers compared to those in other Western nations.”The number one fertility drug is 700 percent higher,” the president asserted. “We’re ending all of that.”
This claim of price disparity is partially accurate, according to Dr. mariana Socal of the Johns Hopkins Bloomberg School of Public Health.”It is indeed true that in this contry we pay on average three to four times higher prices,” Socal explained. “However, these are branded products.” She noted that the opposite is frequently enough true for generic drugs, where Americans typically pay around 15 percent less than consumers in other developed countries.
Socal identified a lack of transparency as a core issue within the U.S. pharmaceutical market. “Prices in the U.S. are not transparent to consumers,” she said. “The same drug can have two different prices-one negotiated by insurers behind closed doors and another, much higher price that people without insurance must pay out of pocket. This really hurts consumers.”
Trump RX: A Direct-to-Consumer Approach
To facilitate access to the discounted IVF medications, the White House announced the creation of a new website, Trump RX, expected to launch in 2026. The platform will sell the medications directly to consumers.
This initiative represents a significant intervention in the pharmaceutical market, signaling a willingness to utilize trade policy and direct-to-consumer sales to address the escalating cost of prescription drugs. The long-term impact of these policies remains to be seen,but the initial declaration offers a glimmer of hope for families struggling with the financial burden of accessing essential medical treatments.
Keep reading
- Trump’s National Guard Deployment in DC Extended to 2029 Amid Autonomy Concerns (archynewsy.com)
- Tariff vs. Price Floor: What Trump's New Solar Rule Does (daybreakwire.com)
